Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 21, 2014

"GEN 10 Awards" Announced

  • Genetic Engineering & Biotechnology News (GEN) announced its 2014 “GEN 10” Award winners for excellence in scientific research. The awards will be presented to ten grad students and postdocs who were among dozens of young investigators to send in abstracts describing a particular research project.

    The award ceremony will take place during the GEN 10 Awards and Grad Bash event on June 26 from 10 am–12 pm in the “What’s Your BIO Theater,” Booth #6039, at the BIO International Conference in San Diego.

    Each of the GEN 10 winners will give a short presentation about their work and each will receive a GEN 10 Award certificate and $50 gift card. Refreshments will be served and all participants and their colleagues will be given the opportunity to mingle and share ideas about their research.

    “As was the case with the two previous GEN 10 Award contests, the GEN editorial team was extremely impressed with the quality of the scientific abstracts we received from these young scientists,” said John Sterling, editor in chief, GEN. “All the research projects were well thought out and reflected in-depth scientific knowledge. The ten winners are to be congratulated for their exceptional accomplishments.”

    The GEN 10 Award winners for 2014 are:

    • Kelvin S.L. Chan, Scripps Research Institute, Abstract: Ligand-enabled cross-coupling of C(Sp3)-H bonds with arylboron reagents via Pd(II)/Pd(0) catalysis
    • Daniel A. Cuevas, San Diego State University, Abstract: High-throughput phenotype profiling for bacterial flux-balance model optimization
    • Bryan Hancock, San Diego State University, Abstract: Zebrafish as a model for Group B streptococcal infection
    • Jennifer Higginbotham, UC-San Diego, Abstract: Hijacking the PRC1 complex to mediate chromatin remodeling and gene silencing at p53 and antiviral promoters
    • Lauryn Keeler, San Diego State University, Abstract: Genomic analysis and characterization of colonizing and invasive Group B streptococcal clinical isolates
    • Brandon Kim, San Diego State University/UC-San Diego Joint Program, Abstract: Regulation of tight junction complexes in brain endothelium by meningeal pathogens
    • Jiun-I Lai, Scripps Research Institute, Abstract: Helper-dependent adenoviral vector (HdAV) genetic correction of Friedreich’s ataxia in iPS cells
    • Tiffany Y. Liang, San Diego State University, Abstract: Characterizing unknown viral genes through metabolomics
    • Erika Olson, Scripps Research Institute, Abstract: Structure-guided optimization of an EphA4 peptide antagonist with applications in neurodegenerative disease
    • Christa Park, UC-San Diego, Abstract: Impact of obesity on intraepithelial lymphocyte homeostasis

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »